Dr. John George Zampella IV, MD

Dr. Zampella practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Zampella's NPI, 1992007413, was assigned on December 4, 2010. Dr. Zampella graduated from Johns Hopkins University School of Medicine in 2013. Dr. Zampella holds New York license 289511.

Dr. Zampella's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Zampella's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Zampella is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Zampella to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zampella practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Zampella's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Zampella is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Zampella's licenses on file in 3 states: New York, Florida and Maryland.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes and joint cyst among the conditions Dr. Zampella treats.

CMS data shows 1,475 Medicare services from Dr. Zampella across 15 procedure codes in 2024, for 510 Medicare patients. Medicare paid $89,237 for them. Every service was in an office.

CMS counts 510 Medicare patients who saw Dr. Zampella in 2024. The largest group is 65 to 74, with 277 patients. 75% of them have high cholesterol, and 58% have high blood pressure. 9% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zampella's median patient age at 50, with 34% women.

In 2024, Dr. Zampella wrote 1,099 Medicare Part D claims for 325 patients. 84% of them were for generic drugs. CMS names the drug for 899 of them, across 21 drugs with 11 or more claims each, at $204,342 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Zampella for performance year 2024, reported as part of a group. Dr. Zampella accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zampella as offering telehealth. CMS counts 380 procedures of removal of skin lesions by Dr. Zampella, more than 84% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 30 papers to Dr. Zampella, published from 2016 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Skin Neoplasms, Dermatologists and Dermatology. Dr. Zampella has published most often in J Am Acad Dermatol. Dr. Zampella's most frequent co-authors are Jorge Roman, MD, Jorge L. Roman, MD and Bernard Alan Cohen, MD.

CMS Open Payments shows 86 general payments to Dr. Zampella from 14 drug and device companies in 2025. Consulting fees make up the largest share, 68% of the total. Arcutis Biotherapeutics, Inc. paid the most, $3,159.

Dr. Zampella graduated from Johns Hopkins University School of Medicine in 2013.

Dr. Zampella is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.